Reply to Evrard and colleagues

References

• 1 Lo G H, Liang H L, Chen W C. et al . A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt vs. cyanoacrylate injection in the prevention of gastric variceal rebleeding.  Endoscopy. 2007;  39 679-685
• 2 Evrard S, Dumonceau J M, Delhaye M. et al . Endoscopic Histoacryl obliteration versus propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial.  Endoscopy. 2003;  35 729-735
• 3 Bernard B, Lebrec D, Mathurin P. et al . Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis.  J Hepatol. 1997;  26 312-324
• 4 Lo G H, Chen W C, Chen M H. et al . A prospective, randomized trial of endoscopic variceal ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.  Gastroenterology. 2002;  123 728-734